Back
Adtran Holdings Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
46
ADTN
Adtran Holdings
Last Price:
$9.46
Seasonality Move:
9.53%
Buy
60
ALNY
Alnylam Pharmaceuticals
Last Price:
$280.77
Seasonality Move:
3.3%
Sell
46
Adtran Holdings (ADTN)
is a Sell
Is Adtran Holdings a Buy, Sell or Hold?
-
The current Adtran Holdings [ADTN] share price is $9.43. The Score for ADTN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
ADTN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ADTN Stock Price Chart
What is Adtran Holdings's stock price today?
-
The Adtran Holdings share price today is $9.43Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADTN is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $290.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
ADTN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 46.29 | Sell |
Chaikin Money Flow: | -663208 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.02 - 11.12) | Sell |
Bollinger Bands (100): | (7.66 - 10.54) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.72 | Buy |
Relative Strength Index (14 RSI): | 71.41 | Buy |
Chaikin Money Flow: | -979016 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.44 - 263) | Buy |
Bollinger Bands (100): | (240.32 - 271.8) | Buy |
ADTN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.08 | Buy |
20-day SMA: | 9.68 | Sell |
50-day SMA: | 10.24 | Sell |
200-day SMA: | 7.33 | Buy |
8-day EMA: | 9.22 | Buy |
20-day EMA: | 9.59 | Sell |
50-day EMA: | 9.72 | Sell |
200-day EMA: | 8.18 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 257.74 | Buy |
20-day SMA: | 249.75 | Buy |
50-day SMA: | 257.54 | Buy |
200-day SMA: | 251.5 | Buy |
8-day EMA: | 263.89 | Buy |
20-day EMA: | 256.08 | Buy |
50-day EMA: | 255.39 | Buy |
200-day EMA: | 243.44 | Buy |
Adtran Holdings Earnings Growth & ADTN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.01 per share, an increase this year of $0.55 per share, and an increase next year of $0.26 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Adtran Holdings Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |